journal article·2017-09

High heparin content surface‐modified polyurethane discs promote rapid and stable angiogenesis in full thickness skin defects through VEGF immobilization

Michelle McLuckie, Christian A. Schmidt, Anel Oosthuysen, Nadia Sanchez‐Macedo, Hannes Merker, Deon Bezuidenhout, Simon P. Hoerstrup, Nicole Lindenblatt

Publisher page

Abstract

Abstract Three‐dimensional scaffolds have the capacity to serve as an architectural framework to guide and promote tissue regeneration. Parameters such as the type of material, growth factors, and pore dimensions are therefore critical in the scaffold's success. In this study, heparin has been covalently bound to the surface of macroporous polyurethane (PU) discs via two different loading methods to determine if the amount of heparin content had an influence on the therapeutic affinity loading and release of (VEGF165) in full thickness skin defects. PU discs (5.4 mm diameter, 300 µm thickness, and interconnected pore size of 150 µm) were produced with either a low (2.5 mg/g) or high (6.6 mg/g) heparin content (LC and HC respectively), and were implanted into the modified dorsal skin chamber (MDSC) of C57BL/6 J mice with and without VEGF. Both low‐ and high‐content discs with immobilized VEGF165 (LCV and HCV, respectively) presented accelerated neovascularization and tissue repair in comparison to heparin discs alone. However, the highest angiogenetic peak was on day 7 with subsequent stabilization for HCV, whereas other groups displayed a delayed peak on day 14. We therefore attribute the superior performance of HCV due to its ability to hold more VEGF165, based on its increased heparin surface coverage, as also demonstrated in VEGF elution dynamics. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 2543–2550, 2017.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Angiogenesis and VEGF in Cancer · Nerve injury and regeneration

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Clinic for Plastic Surgery and Hand Surgery University Hospital Zurich Zurich Switzerland

Division of Surgical Research University Hospital Zurich Zurich Switzerland

Clinic for Cardiovascular Surgery University Hospital Zurich Zurich Switzerland

Division of Cardiothoracic Surgery University of Cape Town Cape Town South Africa

Institute for Regenerative Medicine, University of Zurich Zurich Switzerland

Zurich Center for Integrative Human Physiology (ZIHP) Zurich Switzerland

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

References (33)

Show source-provided references
1. 10.1089/ten.2006.12.209310.1089/ten.2006.12.2093 ↗
2. 10.2174/09298671079320532710.2174/092986710793205327 ↗
3. Experimental approaches to vascularisation within tissue engineering constructs, Journal of Biomaterials Science
4. 10.1159/00033687610.1159/000336876 ↗
5. 10.1016/j.biotechadv.2015.12.00410.1016/j.biotechadv.2015.12.004 ↗
6. 10.1016/j.actbio.2015.08.03010.1016/j.actbio.2015.08.030 ↗
7. 10.1097/00002480-200209000-0000410.1097/00002480-200209000-00004 ↗
8. 10.1042/BST037120110.1042/BST0371201 ↗
9. 10.1002/jemt.1024910.1002/jemt.10249 ↗
10. 10.1177/088532820809756510.1177/0885328208097565 ↗
11. 10.1089/ten.2004.10.150210.1089/ten.2004.10.1502 ↗
12. 10.1016/j.biomaterials.2010.11.03810.1016/j.biomaterials.2010.11.038 ↗
13. 10.1089/ten.tea.2015.049310.1089/ten.tea.2015.0493 ↗
14. 10.1089/ten.tea.2011.019210.1089/ten.tea.2011.0192 ↗
15. Surface bound VEGF and PDGF‐BB stimulate angiogenesis
16. 10.1038/nm0603-65310.1038/nm0603-653 ↗
17. 10.1016/j.bbrc.2005.12.07910.1016/j.bbrc.2005.12.079 ↗
18. 10.1016/j.biomaterials.2009.10.05210.1016/j.biomaterials.2009.10.052 ↗
19. 10.1016/0003-2697(90)90624-I10.1016/0003-2697(90)90624-I ↗
20. 10.1097/PRS.0b013e31818cbeb110.1097/PRS.0b013e31818cbeb1 ↗
21. Enhanced vascularization in hybrid PCL/gelatin fibrous scaffolds with sustained release of VEGF
22. Improved vascularization of porous scaffolds through growth factor delivery from heparinized polyethylene glycol hydrogels
23. 10.1016/j.colsurfb.2015.02.02310.1016/j.colsurfb.2015.02.023 ↗
24. 10.1016/j.jconrel.2010.11.00710.1016/j.jconrel.2010.11.007 ↗
25. 10.1186/2045-824X-4-810.1186/2045-824X-4-8 ↗
26. 10.3390/molecules2004634210.3390/molecules20046342 ↗
27. 10.2174/138161205436755310.2174/1381612054367553 ↗
28. 10.1007/978-1-4899-2444-5_3410.1007/978-1-4899-2444-5_34 ↗
29. 10.1016/j.biomaterials.2013.09.05310.1016/j.biomaterials.2013.09.053 ↗
30. 10.1038/srep1987110.1038/srep19871 ↗
31. 10.1002/adhm.20160005810.1002/adhm.201600058 ↗
32. 10.1002/adhm.20150015410.1002/adhm.201500154 ↗
33. 10.1002/jbm.a.3553110.1002/jbm.a.35531 ↗